OTCMKTS:MKKGY - MERCK KGAA/S Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $20.1960 -0.07 (-0.35 %) (As of 05/22/2019 04:00 PM ET)Previous Close$20.27Today's Range$20.04 - $20.196052-Week Range$19.01 - $23.13Volume9,095 shsAverage Volume23,170 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. Receive MKKGY News and Ratings via Email Sign-up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MKKGY Previous Symbol CUSIPN/A CIKN/A Webhttp://www.merckgroup.com/ Phone+49-6151-720Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees51,039 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable MERCK KGAA/S (OTCMKTS:MKKGY) Frequently Asked Questions What is MERCK KGAA/S's stock symbol? MERCK KGAA/S trades on the OTCMKTS under the ticker symbol "MKKGY." What is the consensus analysts' recommendation for MERCK KGAA/S? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MERCK KGAA/S in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MERCK KGAA/S. Has MERCK KGAA/S been receiving favorable news coverage? Media headlines about MKKGY stock have trended negative on Wednesday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. MERCK KGAA/S earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of MERCK KGAA/S's key competitors? Some companies that are related to MERCK KGAA/S include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Cannabis Science (CBIS), Cannara Biotech (LOVE), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH), Cosmos (COSM) and Curaleaf (CURLF). Who are MERCK KGAA/S's key executives? MERCK KGAA/S's management team includes the folowing people: Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59) How do I buy shares of MERCK KGAA/S? Shares of MKKGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is MERCK KGAA/S's stock price today? One share of MKKGY stock can currently be purchased for approximately $20.1960. What is MERCK KGAA/S's official website? The official website for MERCK KGAA/S is http://www.merckgroup.com/. How can I contact MERCK KGAA/S? MERCK KGAA/S's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The company can be reached via phone at +49-6151-720. MarketBeat Community Rating for MERCK KGAA/S (OTCMKTS MKKGY)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 42 (Vote Outperform)Underperform Votes: 42 (Vote Underperform)Total Votes: 84MarketBeat's community ratings are surveys of what our community members think about MERCK KGAA/S and other stocks. Vote "Outperform" if you believe MKKGY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MKKGY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: Are 12b-1 Fees Affecting Your Mutual Fund Performance? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.